What was hot at the ICS meeting 2015

Alison J. Hainsworth,* Paula Igualada-Martinez, Marianne Koch, Martha Spencer, Martin Slovak, Saladin Alloussi, Christopher Hillary, Bruna M. Couri, Nadir I. Osman, Rufus Cartwright, and Christopher R. Chapple Department of Colorectal, Pelvic Floor Unit, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom Department of Physiotherapy and Pelvic Floor Unit, Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom Department of Obstetrics and Gynaecology, Medical University of Vienna, Vienna, Austria Division of Geriatric Medicine, University of British Columbia, Vancouver, Canada Department of Medical Physics and Clinical Engineering, Sheffield Teaching Hospitals, Royal Hallamshire Hospital, Sheffield, United Kingdom NIHR Devices for Dignity Healthcare Technology Co-operative, Royal Hallamshire Hospitals, Sheffield, United Kingdom Department of Urology, Academic Teaching Hospital of University of Saarland, Stadtisches Klinikum Neunkirchen, Neunkirchen, Germany Department of Urology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom Department of Obstetrics and Gynaecology, Cleveland Clinic Lerner Research Institute, Cleveland Clinic, Cleveland Ohio Cleveland, Ohio Department of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland Clinic, Cleveland Ohio Cleveland, Ohio Department of Urogynaecology, Imperial College London, London, United Kingdom Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom

[1]  J. Weiss,et al.  Fesoterodine for the Treatment of Nocturnal Urgency in Patients with Overactive Bladder Syndrome: An Analysis of Responders and Nonresponders , 2017, The Journal of urology.

[2]  A. Zumrutbas,et al.  The use of biomarkers in the diagnosis and treatment of overactive bladder: Can we predict the patients who will be resistant to treatment? , 2017, Neurourology and urodynamics.

[3]  H. Stenlund,et al.  Non-face-to-face treatment of stress urinary incontinence: predictors of success after 1 year , 2016, International Urogynecology Journal.

[4]  T. Mohr,et al.  Urinary proteomic pattern in female stress urinary incontinence: a pilot study , 2016, International Urogynecology Journal.

[5]  S. Kerr,et al.  Posterior vaginal compartment repairs: Where are the main anatomical defects? , 2016, International Urogynecology Journal.

[6]  F. Valentini,et al.  APPLICATION OF THE D INDEX: NOMOGRAMS ALLOWING EVALUATION OF BLADDER OUTLET OBSTRUCTION (BOO) IN MEN FROM FREE UROFLOWS (FF) , 2015 .

[7]  V. Iakovlev,et al.  Synthetic Mesh Slings: Safety and Risk/Benefit Considerations , 2015 .

[8]  K. Tennankore,et al.  Current Practices in the Surgical Management of Female Stress Urinary Incontinence: A Survey of Canadian Urologists and Gynecologists , 2017, Urology practice.

[9]  R. Mastrigt,et al.  A new nomogram to noninvasively diagnose Bladder Outlet Obstruction using condom catheter measurements , 2015 .

[10]  J. Rho,et al.  Prostatic arterial embolization in patients with benign prostatic hyperplasia: A systematic review and meta-analysis , 2015 .

[11]  M. Oelke,et al.  Symptomatic differences in non-obstructive patients with poor detrusor function versus normal detrusor function , 2015 .

[12]  F. Montorsi,et al.  Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. , 2015, European urology.

[13]  G. Chaves,et al.  MON-PP265: Impact of Perioperative Care on the Postoperative Recovery of Women Undergoing Surgery for Gynecologic Tumors , 2015 .

[14]  H. Dietz,et al.  OC09.03: Does pelvic organ support deteriorate in the years following a first birth? , 2015 .

[15]  M. Lyons,et al.  PWE-378 Total pelvic floor ultrasound in pelvic floor defaecatory dysfunction , 2015 .

[16]  Abdulaziz K Alkattan,et al.  PD1-05 HIGHER NEURAL CORRELATES FOLLOWING INTRAVESICAL BOTULINUM TOXIN- A IN MULTIPLE SCLEROSIS (MS) PATIENTS VIA CONCURRENT FUNCTIONAL MAGNETIC RESONANCE IMAGING (FMRI) AND URODYNAMIC STUDIES (UDS) , 2015 .

[17]  A. Schizas,et al.  The Measurement and Assessment of Rectocoele using Pelvic Floor Ultrasound and Proctography , 2015 .

[18]  W. Whitehead,et al.  PRIMARY CARE PROVIDER OPINIONS AND PRACTICES REGARDING SCREENING FOR URINARY AND FAECAL INCONTINENCE (ACCIDENTAL BOWEL LEAKAGE) , 2015 .

[19]  M. Wise,et al.  DEVELOPMENT OF AN INSTRUMENT TO ASSESS BARRIERS TO CARE-SEEKING FOR FAECAL INCONTINENCE (ACCIDENTAL BOWEL LEAKAGE) , 2015 .

[20]  J. Delanghe,et al.  Haptoglobin polymorphism : an explanation for global polyuria? , 2015 .

[21]  H. Nakagawa,et al.  Association between nocturnal voiding, arousal during sleep and the incidence rate of falls: A community-based study with home-visit interview , 2015 .

[22]  L. Xiao,et al.  CONTINENCE NURSE ADVISORS’ ASSESSMENT AND MANAGEMENT STRATEGIES FOR INCONTINENCE IN HOME-DWELLING OLDER PEOPLE WITH DEMENTIA , 2015 .

[23]  P. Culligan,et al.  The TOPAS™ System for fecal incontinence: A close look at complications , 2015 .

[24]  C. Gratzke,et al.  Minimally Invasive Prostatic Urethral Lift (PUL) Efficacious In A Large Percentage of Potential TURP Candidates: Mid-term Results , 2015 .

[25]  G. Guyatt,et al.  Long-term impact of mode of delivery on stress and urgency urinary incontinence: a systematic review and meta-analysis , 2015 .

[26]  S. MacNeil,et al.  The in vivo response to implantable engineered repair materials designed for pelvic floor reconstruction , 2015 .

[27]  A. Markland,et al.  Association of nocturia with poor functional outcomes of sleep among a population-based sample of men and women , 2015 .

[28]  M. Helal,et al.  Bladder surveillance in SCI patient with long term SPC for more than 15 years , 2015 .

[29]  D. Parkin,et al.  Long term cost effectiveness of botulinum toxin A and sacral neuromodulation for patients with refractory overactive bladder. , 2015 .

[30]  J. Lavelle,et al.  Frequent UTIs are Associated with Bladder Management Changes in Veterans with Spinal Cord Injury , 2015 .

[31]  Yuan-Hong Jiang,et al.  Predictors of Adverse Events after OnabotulinumtoxinA Treatment for Patients with Overactive Bladder Syndrome , 2015 .

[32]  R. Rosen,et al.  A combination therapy with low dose desmopressin and tolterodine improves health-related quality of life in female patients with overactive bladder and nocturnal polyuria , 2015 .

[33]  C. Ros,et al.  PREVALENCE AND REMISSION RATE OF URINARY INCONTINENCE IN UNTREATED WOME. A COHORT STUDY IN WOMEN SEEKING CARE FOR GYNAECOLOGICAL PROBLEMS. , 2015 .

[34]  L. Christensen,et al.  Potential improvement of pelvic organ prolapse surgery outcome using a long-term degradable scaffold with or without autologous muscle fiber fragments – a pilot study with three abdominal models in rats. , 2015 .

[35]  S. MacNeil,et al.  Response of scaffold materials designed for treatment of stress urinary incontinence (SUI) and pelvic organ prolapse (POP) to distension , 2015 .

[36]  O. Borisenko,et al.  The cost-utility of Sacral Neuromodulation versus Botulinum Toxin A for the treatment of refractory idiopathic overactive bladder (with urgency urinary incontinence) in Sweden , 2015 .

[37]  P. Dasgupta,et al.  Adverse Events with Botox and Dysport for refractory overactive bladder: A systematic review , 2015 .

[38]  H. Stenlund,et al.  High Expectations for Pelvic Floor Muscle Training with Mobile Application Predicts Successful Treatment in Women with Stress Urinary Incontinence , 2015 .

[39]  D. Ridder,et al.  Clinically Meaningful Improvements in Urinary Incontinence Following Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study , 2015 .

[40]  P. Rosier.  Intra- prostatic protrusion shows a typical urodynamic pattern on pressure flow analysis. , 2015 .

[41]  J. Nørgaard,et al.  Low dose desmopressin and tolterodine for nocturia in female patients with overactive bladder: a randomized, double-blind, placebo-controlled study , 2015 .

[42]  J. Rejas,et al.  Medical Outcomes Study Sleep Scale (MOS- Sleep Scale) in the detection of Overactive Bladder in Spanish population. , 2015 .

[43]  H. Akino,et al.  Low-frequency transcutaneous electrical stimulation of foot ameliorates intractable OAB symptoms , 2015 .

[44]  C. Dumoulin,et al.  Effect of physiotherapy on pelvic floor morphometry in women with and without avulsion injury of the puborectalis muscle after vaginal delivery: a randomised pilot study. , 2015 .

[45]  H. Stenlund,et al.  Treatment of Stress Urinary Incontinence via a Smartphone Application: a Randomised Controlled Trial , 2015 .

[46]  L. Carucci,et al.  Use of real-time ultrasound and continuous urgency meter during urodynamics , 2015 .

[47]  J. Roppolo,et al.  ELECTRICAL STIMULATION OF SOMATIC AFFERENT NERVES IN THE FOOT IMPROVES OVERACTIVE BLADDER SYMPTOMS , 2015 .

[48]  A. Suskind,et al.  Flurourodynamic Studies Change Urology Provider Impressions and Management Plans , 2015 .

[49]  L. Brubaker,et al.  PRE-OPERATIVE URINARY MICROBIOME REVEALS POST-OPERATIVE URINARY TRACT INFECTION RISK , 2015 .

[50]  X. Deffieux,et al.  French Multicenter Randomized Study Comparing Laparoscopic Sacropexy and Vaginal Mesh Surgery in Cystocele Repair: a preliminary analysis of anatomical and functional outcomes in PROSPERE RCT , 2015 .

[51]  L. Brubaker,et al.  THE FEMALE URINARY MICROBIOTA RELATES TO INCONTINENCE MEDICATION EFFICACY , 2015 .

[52]  A. Cameron,et al.  Gentamicin Bladder Instillations Decrease Symptomatic Urinary Tract Infections and Oral Antibiotic Use in Patients on Intermittent Catheterization , 2015 .

[53]  A. Barker,et al.  Home based therapeutic application of non-invasive posterior tibial nerve stimulation in the treatment of overactive bladder symptoms: a pilot clinical trial , 2015 .